What is the treatment for exogenous ochronosis with tretinoin (all-trans retinoic acid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Tretinoin may be used as a treatment for exogenous ochronosis, typically applied as a 0.05-0.1% cream once daily at bedtime, as it increases cell turnover and promotes exfoliation of the hyperpigmented skin containing homogentisic acid deposits, although the most recent and highest quality study 1 suggests that treatment of this condition is often unsatisfactory. The treatment regimen should start with application every other night for 2-4 weeks to minimize irritation, then gradually increase to nightly use as tolerated. Patients should apply a pea-sized amount to affected areas after cleansing and drying the skin. Some key points to consider when treating exogenous ochronosis with tretinoin include:

  • Treatment duration is typically several months, with improvements potentially seen after 3-6 months of consistent use.
  • Strict sun protection is essential as tretinoin increases photosensitivity.
  • Patients may experience side effects including redness, dryness, peeling, and irritation.
  • For severe cases, combination therapy with other depigmenting agents like hydroquinone (under medical supervision), chemical peels, or laser therapy may be more effective than tretinoin alone.
  • Results are generally gradual, and complete resolution of pigmentation may not be achievable in all cases, as noted in the study 1. It is also important to note that the use of hydroquinone in concentrations above 4% and in treatment courses longer than 3 months may be associated with new-onset ochronosis, as reported in the study 1. Some other key considerations include:
  • The condition is often difficult to treat, and treatment options are limited, as noted in the studies 2, 3, and 4.
  • Exogenous ochronosis is a rare condition, but it can be cosmetically disfiguring and troubling for patients, as reported in the study 4.
  • The condition is often associated with the use of skin-lightening creams containing hydroquinone, as noted in the studies 2, 3, and 1.

References

Research

Exogenous ochronosis associated with hydroquinone: a systematic review.

International journal of dermatology, 2022

Research

Exogenous ochronosis: case report and literature review.

Anais brasileiros de dermatologia, 2012

Research

Exogenous Ochronosis.

Indian journal of dermatology, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.